We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 97.50 | 95.00 | 100.00 | 97.50 | 97.50 | 97.50 | 5,188 | 07:36:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2015 10:01 | One thing you do have going for FDBK is the Nigel Wray stance of directors equities - 2 major shareholders are dirs and hold quite a bit of the equity thus in line with interests of other shareholders - If there is any traction perhaps a partnership would be helpful - One of things I look for for long term investing is how big the company is and can they devlelop partnerships. If so, how big is the partner - Is teh partner big enough? | tomboyb | |
22/4/2015 09:57 | Trevor Brown is a Director here and before that at AVO. | blueball | |
22/4/2015 09:51 | That was TB or Freddy as he is known. Probably best not to bring that up again he is quite arrogant and refuse to admit what a amazing call Freddy made with Care/Avo. Now can the same happen here. Look at the Cap of Avo and look at the Cap of Agl there is room for a re-rating where cancer is concerned. | 21trader | |
22/4/2015 09:47 | I remember at 0.90p - lol CR was having a spat with a very large shareholder in care capital - AIM is a minefield - It can make a fortune or lose it equally | tomboyb | |
22/4/2015 09:43 | I remember when I was almost the only poster on the AVO thread when it was 0.8p and unloved and Trevor Brown used to pop along with the odd snippet and was buying the odd million shares on the market and from the odd placing. It was totally unloved as most bombed out stocks are. Market cap was about 3-5 million. It's just hit 150 million market cap and price has 15 folded in only a few years things can change quickly and sentiment with it. | 21trader | |
22/4/2015 09:32 | I don't think the potential of the recent kidney stones collaboration with Oxford Stone Group has been thought through. 7 billion people globally, of these 3-5% will get kifdney stones, say 4% = 280 million. Of these, half will be treated by lithotripsy = 140 million cases Of which half is ineffective = 70 million cases. The average cost of Lithotripsy (£2k in the UK but $10k in the USA), say £3k. The total cost of wasted Lithotripsy = £21 billion, over an average life span so £21 billion divided by 70 would give value of world wasted market of around £300m pa. Thats just kidney stones market - the potential application for Texrad etc is huge. | zeuss1 | |
22/4/2015 09:29 | I would add that so far its very early days for this company - The Growth of AVO has been a lot about its technology and the team they have devloped over time - FDBK is tiny at this stage - But who knows | tomboyb | |
22/4/2015 09:26 | Thanks tom I've bought some this am. | blueball | |
22/4/2015 09:17 | IS this Beauty the next Advanced Oncotherapy? – That’s What I Heard at the Big UK Investor Show. hxxp://www.shareprop | tomboyb | |
22/4/2015 09:12 | Whats he saying tia. | blueball | |
22/4/2015 09:11 | It seems Malcom Stacy has got a hold of this on ShareProphets - | tomboyb | |
22/4/2015 08:13 | Reading in more detail... 'Labour says the money will enable more ultrasound and X-ray machines to be installed directly into GP surgeries so patients can get cancer tests on the premises' Considering the pressure on General Practice, is this really the place we want cancer tests done? | davydoo | |
22/4/2015 08:11 | Just realised what an interesting stock photo the BBC chose, it looks like very big breasts on very old screens! | davydoo | |
22/4/2015 07:59 | Labour pledge £150m for better Cancer diagnosis I doubt this is a Labour only thing either, like I said to Norbert spending on health is only going up, and spending on things that improve efficiency and reduce cost or patient wait times particularly. | davydoo | |
21/4/2015 18:41 | Agree with you on the trades Davydoo - I reckon all buys too. I got quotes 3 times today between 10:30am and 3pm and on all 3 occasions the quote given was 1.65p - 1.7599p (for 100k max - above that the price rose to 1.81p). | lr2 | |
21/4/2015 15:05 | based on dummy trades i've done, I reckon all today's trades are buys. Add to that what LR2 said and most of yesterday's trades were buys too. My recent trades were all buys, so where/who are the sales? | davydoo | |
21/4/2015 13:38 | Lithotripsy costs $10k (USA) or £2,500 (Uk), half is ineffective, stones incidence is 3-5%, world 7bn = 300m cases. That's a lot of potential money to be saved (if trial is successful) Anyone had lithotripsy? Or is anyone a doctor working in this field and can comment? | alicia1983 | |
21/4/2015 10:42 | Davy - I like your SIPP strategy which is somewhat similar to mine. Whilst my SIPP could be deemed generally high risk as most holdings are sub GBP 150m, I hold a mixture of good quality companies such as APH, WTM and ALY which pay a good divi and then contrast this with some more speculative holdings such as FDBK, AMBR, NCON and ZZZ. My overall pension situation is pretty dire given my age (early / mid 40s) and I need to (and still have the time to) take some risks. Keeps me on my toes anyway....good luck and hope to see you around at some point. | norbert colon | |
21/4/2015 09:51 | Considering the spread issues this has had its currently 1.65 - 1.71 That's pretty tight | davydoo | |
20/4/2015 16:35 | Stig, re your post #514 - "expect the recent promotion is because a placing is in the works". Their previous placing was at a 62% premium. Perhaps they can do the same again. Good to see your first 2 postings here are so positive Stig. (Sarcasm). | lr2 | |
20/4/2015 16:02 | the balance sheet is very weak expect the recent promotion is because a placing is in the works | the stigologist | |
20/4/2015 15:59 | Who can comprehend the arcane ways of the market makers Davydoo? I guess they either have a large delayed sell waiting to appear or they don't want the ordinary bloke in the street to see the interest that is developing here. If you like sleepy little backwater shares that are suddenly showing a few surface ripples, you might want to do a bit of digging into Eden Research (EDEN). Been some buying going on there on Friday and today. | lr2 | |
20/4/2015 15:42 | thanks LR2 wonder why they raised the price and then sell below mid? I paid 1.69p on Friday when most other trades were 1.70p so it seems odd if you're paying 1.645p today. Well done though! | davydoo | |
20/4/2015 14:49 | They aren't sells Davydoo. The recent 100k at 1.645p is my purchase. | lr2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions